Stay updated on Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial page.

Latest updates to the Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe record history now includes a later submitted version (dated 2026-03-27) showing the study status change and additional sections populated/available such as participant flow, baseline characteristics, outcome measures (results), and adverse events. It also shows that the results were returned on 2026-04-16 with “Quality Control Review Has Not Concluded,” meaning the trial’s results have progressed to a new stage of the record lifecycle.SummaryDifference1%

- Check23 days agoChange DetectedAdded revision v3.5.2 and removed revision v3.5.0 from the record history.SummaryDifference0.1%

- Check38 days agoChange DetectedRecord history adds 'Results Submitted' as a new status, replacing the previous 'No Results Posted'.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the record history.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the history.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision: v3.4.2 was added to the record history; the old government-funding notice and the previous Revision: v3.4.1 entry were removed.SummaryDifference0.9%

Stay in the know with updates to Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial page.